We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 692

Patent Wars - Round two in favour of Novartis as Cipla unable to mount credible challenge
  • RNA IP Attorneys
  • India
  • March 20 2017

The two judges bench (Division Bench) of the Delhi High Court has upheld the decision of a single judge restraining Cipla from selling generic


Compulsory licensing: law, challenges and strategies
  • LexOrbis
  • India
  • March 8 2017

The compulsory licensing provision is one of the most widely debated provisions of the Patents Act 1970 as it concerns the grant of a compulsory


Delhi High Court grants temporary Injunction against Macleods Pharmaceuticals Ltd
  • SS Rana & Co
  • India
  • February 22 2017

In a recent case decided by the Delhi High Court, Justice R.K.Gauba granted temporary injunction in favor of Intas Pharmaceuticals Ltd (hereinafter


India Notifies New Medical Devices Rules
  • Squire Patton Boggs
  • India
  • February 20 2017

On January 31, 2017, the Indian government notified the Medical Devices Rules 2017 under the Drugs and Cosmetics Act 1940. The rules simplify the


India: In an effort to provide conducive environment to domestic manufacturers, Government notifies New Rules for Medical Devices
  • SS Rana & Co
  • India
  • February 17 2017

The Government of India, under the aegis of Ministry of Health and Family Welfare has notified the Medical Devices Rules, 2017, which is scheduled to


Highlights of India's 2017 Union Budget
  • Squire Patton Boggs
  • European Union, India, OECD, United Kingdom
  • February 8 2017

India's budget for 2017 was unique because it changed the tradition of being presented on the last day of February and, for the first time in


New rules for medical devices
  • Khaitan & Co
  • India
  • February 7 2017

On 31 January 2017, the Ministry of Health and Family Welfare notified the Medical Devices Rules, 2017 (Rules) under the Drugs and Cosmetics


India: Delhi High Court grants injunction in favor of GSK
  • SS Rana & Co
  • India
  • December 20 2016

In this case, Glaxosmithkline Pharmaceuticals (hereinafter referred to as the 'Plaintiff') filed a suit against Sarath Kumar Reddy (hereinafter


Delhi High Court strikes down notification dated 10 March 2016 issued by the government of India banning 344 fixed dose combination (FDC) drugs
  • Khaitan & Co
  • India
  • December 5 2016

A single judge of the Delhi High Court, Justice Rajiv Sahai Endlaw vide his Order and Judgment dated 1 December 2016 has struck down the notification


The real meaning of 'efficacy'
  • LexOrbis
  • India
  • November 30 2016

In 2005 India amended the Patents Act to introduce protection for product inventions, including patents for pharmaceuticals. Section 3(d) of the